CAMKK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.043800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.657620E-02
Normal-vs-Stage2
2.805600E-02
Normal-vs-Stage3
1.148020E-01
Normal-vs-Stage4
8.429800E-02
Stage1-vs-Stage2
4.080200E-01
Stage1-vs-Stage3
8.002600E-01
Stage1-vs-Stage4
5.240800E-01
Stage2-vs-Stage3
7.265400E-01
Stage2-vs-Stage4
9.753600E-01
Stage3-vs-Stage4
8.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.544500E-02
Normal-vs-AfricanAmerican
7.731600E-02
Normal-vs-Asian
6.442600E-03
Caucasian-vs-AfricanAmerican
9.501400E-01
Caucasian-vs-Asian
1.518820E-01
AfricanAmerican-vs-Asian
3.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.427900E-02
Normal-vs-Female
5.518500E-03
Male-vs-Female
8.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.383800E-02
Normal-vs-Age(41-60Yrs)
1.168260E-02
Normal-vs-Age(61-80Yrs)
2.321800E-02
Normal-vs-Age(81-100Yrs)
1.317830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.568980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.826600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.369800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.170570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.218800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.061990E-02
Normal-vs-Daily Drinker
5.921100E-03
Normal-vs-Weekly Drinker
4.594100E-02
Normal-vs-Occasional Drinker
7.603200E-03
Normal-vs-Social Drinker
1.328130E-02
Non Drinker-vs-Daily Drinker
8.794400E-01
Non Drinker-vs-Weekly Drinker
3.698800E-01
Non Drinker-vs-Occasional Drinker
8.871200E-01
Non Drinker-vs-Social Drinker
3.806000E-01
Daily Drinker-vs-Weekly Drinker
3.056600E-01
Daily Drinker-vs-Occasional Drinker
9.998600E-01
Daily Drinker-vs-Social Drinker
2.997200E-01
Weekly Drinker-vs-Occasional Drinker
3.307200E-01
Weekly Drinker-vs-Social Drinker
9.259400E-01
Occasional Drinker-vs-Social Drinker
3.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.451800E-01
Normal-vs-Grade 2
2.403700E-02
Normal-vs-Grade 3
7.601900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.604100E-03
Grade 1-vs-Grade 3
1.875130E-03
Grade 1-vs-Grade 4
4.451800E-01
Grade 2-vs-Grade 3
3.290200E-01
Grade 2-vs-Grade 4
2.403700E-02
Grade 3-vs-Grade 4
7.601900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.601600E-03
Normal-vs-NonDiabetic
4.940600E-03
Diabetic-vs-NonDiabetic
7.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.007600E-02
Normal-vs-NoPancreatitis
4.658600E-03
Pancreatitis-vs-NoPancreatitis
3.280000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.483400E-03
Normal-vs-N1
3.576100E-02
N0-vs-N1
4.754400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.242400E-02
Normal-vs-TP53-NonMutant
4.040400E-02
TP53-Mutant-vs-TP53-NonMutant
2.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
